Unusual New HIV Drug Resistance Mechanism Revealed

WASHINGTON D.C. Feb. 18, 2014 -- For the more than one million people with HIV/AIDS in the United States , antiretroviral drugs such as efavirenz and other so-called non-nucleoside reverse transcriptase inhibitors in combination with other antiretrovirals can be a lifeline, because they slow the progress of viral infection, prolonging life.

http://ift.tt/1nLv5Ar